V9 Anti-Human CTLA4 (Ipilimumab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
CTLA-4
Purification
IEC
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG1 (K214R/E356D/M358L) -Kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx03304-inquire Inquire
Recombinant Haemophilus Influenzae hgbC Protein (aa 1-993)
Sign In for Pricing
View Details 
MBS6376527-01 0.1 mL
DOK1 (Docking Protein 1, Downstream Of Tyrosine Kinase 1, p62(dok), pp62) (FITC)
Sign In for Pricing
View Details MBS6376527-02 5x 0.1 mL
DOK1 (Docking Protein 1, Downstream Of Tyrosine Kinase 1, p62(dok), pp62) (FITC)
Sign In for Pricing
View Details MBS1036837-01 0.02 mg (E-Coli)
Recombinant Anabaena cylindrica Allophycocyanin beta chain (apcB)
Sign In for Pricing
View Details MBS1036837-02 0.1 mg (E-Coli)
Recombinant Anabaena cylindrica Allophycocyanin beta chain (apcB)
Sign In for Pricing
View Details